HomeInsightsDividend

Jenburkt Pharmaceuticals Ltd dividend

Jenburkt Pharmaceuticals Ltd dividend

download
stocks purchased

₹ 0.2 Cr

Volume transacted

stocks purchased

2.6 K

stocks traded

Last Updated time: 18 Jul 15:30 PM

Image

Jenburkt Pharmaceuticals Ltd

NSE: JENBURKTPHARMA

DPS

15.3

Last updated : FY 2024

Key Highlights

    The Dividend per Share of Jenburkt Pharmaceuticals Ltd is ₹ 15.3 as of 2024 .a1#The Dividend Payout of Jenburkt Pharmaceuticals Ltd changed from 23.65 % on March 2019 to 25.97 % on March 2024 . This represents a CAGR of 1.57% over 6 years. a1#The Latest Trading Price of Jenburkt Pharmaceuticals Ltd is ₹ 870.75 as of 18 Jul 15:30 .a1#The Market Cap of Jenburkt Pharmaceuticals Ltd changed from ₹ 231.86 crore on March 2019 to ₹ 304.27 crore on March 2024 . This represents a CAGR of 4.63% over 6 years. a1#The Revenue of Jenburkt Pharmaceuticals Ltd changed from ₹ 32.27 crore to ₹ 40.03 crore over 8 quarters. This represents a CAGR of 11.38% a1#The EBITDA of Jenburkt Pharmaceuticals Ltd changed from ₹ 8.42 crore to ₹ 11.04 crore over 8 quarters. This represents a CAGR of 14.51% a1#The Net Pr of Jenburkt Pharmaceuticals Ltd changed from ₹ 5.95 crore to ₹ 7.88 crore over 8 quarters. This represents a CAGR of 15.08% a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Share Price Vs Dividend Yield

swot
swot

Company Fundamentals For Jenburkt Pharmaceuticals Ltd

Market Cap

384 Cr

EPS

58.8

P/E Ratio (TTM) *

14.8

P/B Ratio (TTM) *

2.7

DTE *

0.0

ROE *

17.9

ROCE *

24.0

Dividend Yield *

2.22

DPS *

15.3

Dividend Payout *

25.97

Ann.Dividend % *

153

* All values are consolidated

Last Updated time: 18 Jul 15:30 PM

* All values are consolidated

Last Updated time: 18 Jul 15:30 PM

×

Historical Dividend Payout of Jenburkt Pharmaceuticals Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Jenburkt Pharmaceuticals Ltd

Period
Mar '1924
Mar '2025
Mar '2128
Mar '2225
Mar '2326
Mar '2426

* All values are a in %

Dividend per Share (DPS) Over Time

×

DIVIDENDYIELD

Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.

Dividend Yield Comparison With Top Peers

1M

1Y

3Y

5Y

* All values are in %

Net Profit Vs Dividend Per Share

Image

Jenburkt Pharmaceuticals Ltd

NSE: JENBURKTPHARMA

PRICE

870.75

-3.25 (-0.37%)

stock direction

Last updated : 18 Jul 15:30

SWOT Analysis Of Jenburkt Pharmaceuticals Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

Overview of Dividend

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


×

Historical Market Cap of Jenburkt Pharmaceuticals Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Jenburkt Pharmaceuticals Ltd

Period
Mar '19232
Mar '20146
Mar '21183
Mar '22260
Mar '23294
Mar '24304

* All values are a in crore

×

Historical Revenue of Jenburkt Pharmaceuticals Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Jenburkt Pharmaceuticals Ltd

Period
Jun '2232
Sep '2237
Dec '2236
Mar '2336
Jun '2330
Sep '2339
Dec '2337
Mar '2440

* All values are a in crore

×

Historical EBITDA of Jenburkt Pharmaceuticals Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Jenburkt Pharmaceuticals Ltd

Period
Jun '228
Sep '2210
Dec '228
Mar '239
Jun '238
Sep '2310
Dec '239
Mar '2411

* All values are a in crore

×

Historical Net Profit of Jenburkt Pharmaceuticals Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Jenburkt Pharmaceuticals Ltd

Period
Jun '226
Sep '227
Dec '225
Mar '236
Jun '235
Sep '237
Dec '235
Mar '248

* All values are a in crore

About Jenburkt Pharmaceuticals Ltd

About Jenburkt Pharmaceuticals Ltd

    Jenburkt Pharmaceuticals Ltd, incorporated in 1985, was formed a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe. The organisation caters to government, semi-government institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at Sihor-Gujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements. In addition, it has a Research & Development unit duly approved by the Ministry of Science & Technology, Government of India. Hence, the Company has strong manufacturing facilities to cater to domestic and international market. The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, life-changing therapeutic solutions that are accessible to all. Way back in the 20th century, a visionary in the field of healthcare and philanthropic work - Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies. Continuing the legacy of Shri Nandlal Mulji Bhuta, his sons Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta founded the Company. In 2021-22, the Company launched a new OTC division ~ Jenburkt Wellness towards better physical and mental health. The first brand launched was Zixa Strong, natural, pain relief product. Further, it launched Nervijen D3 tablets in 2022-23.

Jenburkt Pharmaceuticals Ltd News Hub

News

Jenburkt Pharmaceuticals to conduct AGM

Jenburkt Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the compa...

Read more

24 Jun 202409:36

News

Board of Jenburkt Pharmaceuticals recommends final dividend

Jenburkt Pharmaceuticals announced that the Board of Directors of the Company at its meeti...

Read more

29 May 202410:57

News

Jenburkt Pharmaceuticals schedules board meeting

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2...

Read more

21 May 202415:36

News

Jenburkt Pharmaceuticals to announce Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6...

Read more

20 Jan 202412:45

News

Jenburkt Pharmaceuticals to table results

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7...

Read more

30 Oct 202314:04

News

Jenburkt Pharmaceuticals announces board meeting date

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8...

Read more

26 Jul 202311:51

FAQs for dividends of Jenburkt Pharmaceuticals Ltd

What is the current market price of Jenburkt Pharmaceuticals Ltd Ltd as of July 18, 2024?

The current market price of Jenburkt Pharmaceuticals Ltd Ltd stands at 870.8 per share.

What dividend did Jenburkt Pharmaceuticals Ltd declare in the last fiscal year?

In the last fiscal year, Jenburkt Pharmaceuticals Ltd declared a dividend totaling ₹15.3.

What is the most recent dividend declared by Jenburkt Pharmaceuticals Ltd?

Jenburkt Pharmaceuticals Ltd recently declared a dividend of 0.0 in the latest quarter

How many times has Jenburkt Pharmaceuticals Ltd declared dividends in the current fiscal year

Jenburkt Pharmaceuticals Ltd has declared dividends 4 times totaling ₹0 in the current fiscal year (FY2023-2024).

How many times did Jenburkt Pharmaceuticals Ltd declare dividends in the previous fiscal year?

In the previous fiscal year (FY2022-2023), Jenburkt Pharmaceuticals Ltd declared dividends 4 times totaling ₹0.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199